← Back to Search

Filter Ventilation for Tobacco Use

N/A

Waitlist Available

Led By Dorothy K Hatsukami, Ph.D

Research Sponsored by Masonic Cancer Center, University of Minnesota

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

At least 21 years of age

Be older than 18 years old

Must not have

Unstable medications

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 7 days prior to baseline visit and 7 days prior to week 6 visit

Awards & highlights

No Placebo-Only Group

Summary

This trial will test the effects of different degrees of cigarette filter ventilation on biomarkers of exposure to toxins and on smoking behavior. Additionally, the study will explore how these changes impact a smoker's dependence on cigarettes and their subjective responses to smoking.

Who is the study for?

This trial is for regular cigarette smokers who are at least 21 years old and have their smoking status confirmed biochemically. It's not suitable for individuals with unstable health conditions, those on fluctuating medications, or pregnant or nursing women.

What is being tested?

The study is testing the effects of cigarettes with ventilated filters versus unventilated filters on toxicant exposure and smoking behavior. Participants will be monitored for changes in urinary biomarkers and their responses to the cigarettes.

What are the potential side effects?

While specific side effects are not detailed, potential risks may include changes in smoking behavior due to different filter types which could affect toxin intake.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am at least 21 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

My medications have been stable for the last month.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 7 days prior to baseline visit and 7 days prior to week 6 visit

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~7 days prior to baseline visit and 7 days prior to week 6 visit

This trial's timeline: 3 weeks for screening, Varies for treatment, and 7 days prior to baseline visit and 7 days prior to week 6 visit for reporting.